位置:成果数据库 > 期刊 > 期刊详情页
原发性胆汁性肝硬化血清蛋白质谱的初步研究
  • 期刊名称:肝脏
  • 时间:0
  • 页码:254-258
  • 语言:中文
  • 分类:R392.11[医药卫生—免疫学;医药卫生—基础医学]
  • 作者机构:[1]第二军医大学长征医院实验诊断科,上海200003
  • 相关基金:国家自然科学基金资助项目(No.30770997,No.30772017,No.30972730); 上海市科委基金资助项目(No.09JC1405400,No.08QH14001)
  • 相关项目:原发性胆汁性肝硬化胆管上皮细胞比较蛋白质组研究
中文摘要:

MicroRNA(miRNA)是机体调控基因转录后沉默的重要分子,参与免疫细胞发育和炎症等多种生理病理过程,其中重要的miRNA有miR-155、miR-17~92、miR-146a、miR-150和miR-181a等。miR-155与T、B细胞的分化以及B细胞抗体类别转换密切相关,miR-17~92参与B细胞发育,miR-150负向调控B细胞发育和炎症反应,miR-181a参与T细胞发育,miR-146a负向调控炎症反应。研究miRNA的免疫调控作用及其机制,将推动免疫学的理论研究及其在免疫相关疾病防治中的应用。

英文摘要:

MicroRNA (miRNA),an important post-transcriptional regulator,is involved in a variety of physical and pathological processes,including the development of immune cells and inflammation response.Among them,miR-155,miR-17~92,miR-146a,miR-150,and miR-181a are extremely important.MiR-155 is an essential regulator for T and B cell differentiation and antibody class switch of B cells,miR-17~92 is associated with the development of B cells,miR-150 negatively regulates the development of B cells and inflammation response,miR-181a participates in the development of T cells,and miR-146a is a negative regulator of inflammatory response.Further understanding of the regulatory function of miRNA on immune cells and their mechanisms will promote immunology research and its application in the prevention and treatment of immuno-related diseases.

同期刊论文项目
同项目期刊论文